Wakabayashi Hiroshi, Konishi Tahahiro, Yoneyama Hiroto, Inaki Anri, Hiromasa Tomo, Yamase Takafumi, Akatani Norihito, Watanabe Satoru, Mori Hiroshi, Kayano Daiki, Kinuya Seigo
Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Department of Radiological Technology, Kanazawa University Hospital, Kanazawa, Japan.
Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):115-120. doi: 10.22038/AOJNMB.2019.35953.1245.
Single-photon emission computed tomography (SPECT) using metaiodobenzylguanidine (MIBG) is an important diagnostic tool for the treatment of refractory pheochromocytoma and paraganglioma (PPGL). Owing to the difficulty of SPECT quantification, the tumour-to-background ratio (TBR) is used to assess disease activity. However, the utility of TBR is limited owing to the background setting. A quantification technique of SPECT/computed tomography (CT) would facilitate image interpretation. This study aimed to assess the relationship between I-MIBG maximum standardized uptake value (SUV) and TBR and levels of urinary catecholamines and metabolites in patients with refractory PPGL.
This study included 15 patients with refractory PPGL who underwent I-MIBG therapy. Overall, 27 I-MIBG SPECT/CT images were acquired before and after the therapy. Lesions observed on whole-body images were analysed; the maximum number of lesions per scan was 10. I-MIBG SUV was semi-automatically calculated using Q. Metrix package (GE Healthcare). TBR was manually calculated according to the following formula: (max count in lesion - max count in background)/max count in background. Background was set in the contralateral area. When a background region of interest could not be set in the area, it was set in the thigh area. Urine was sampled for 24 h to measure catecholamine and metabolite levels. Increases of ≥3-fold were considered abnormal. TBR, I-MIBG SUV and urinary catecholamine and metabolite levels were compared using linear regression analysis.
All patients had MIBG-avid lesions, as seen on I-MIBG SPECT/CT. A significant relationship between I-MIBG SUV and TBR was observed (correlation coefficient [r] =0.84, P < 0.0001). In 27 SPECT/CT examinations, normetanephrine (NMN) level was abnormally increased in 51% (14/27), but other catecholamine and other metabolites were abnormally increased in < 26% (7/27). I-MIBG SUV strongly correlated with NMN (r=0.76, P < 0.01) and log NMN (r=0.74, P < 0.01).
I-MIBG SUV demonstrated similar trends as TBR and reflected urinary NMN in patients with refractory PPGL. Semi-automatic quantification of SPECT/CT could be a useful tool for the evaluation of disease activity.
使用间碘苄胍(MIBG)的单光子发射计算机断层扫描(SPECT)是治疗难治性嗜铬细胞瘤和副神经节瘤(PPGL)的重要诊断工具。由于SPECT定量困难,肿瘤与本底比值(TBR)被用于评估疾病活动度。然而,由于本底设置的原因,TBR的效用有限。SPECT/计算机断层扫描(CT)定量技术将有助于图像解读。本研究旨在评估难治性PPGL患者中I-MIBG最大标准化摄取值(SUV)与TBR以及尿儿茶酚胺和代谢物水平之间的关系。
本研究纳入了15例接受I-MIBG治疗的难治性PPGL患者。总共在治疗前后获取了27张I-MIBG SPECT/CT图像。分析全身图像上观察到的病变;每次扫描的最大病变数为10个。使用Q.Metrix软件包(GE医疗)半自动计算I-MIBG SUV。根据以下公式手动计算TBR:(病变中的最大计数-本底中的最大计数)/本底中的最大计数。本底设置在对侧区域。当在该区域无法设置本底感兴趣区时,则设置在大腿区域。采集24小时尿液样本以测量儿茶酚胺和代谢物水平。增加≥3倍被认为异常。使用线性回归分析比较TBR、I-MIBG SUV以及尿儿茶酚胺和代谢物水平。
所有患者在I-MIBG SPECT/CT上均可见MIBG摄取阳性病变。观察到I-MIBG SUV与TBR之间存在显著相关性(相关系数[r]=0.84,P<0.0001)。在27次SPECT/CT检查中,去甲变肾上腺素(NMN)水平异常升高的占51%(14/27),但其他儿茶酚胺和其他代谢物异常升高的比例<26%(7/27)。I-MIBG SUV与NMN(r=0.76,P<0.01)和log NMN(r=0.74,P<0.01)强烈相关。
I-MIBG SUV在难治性PPGL患者中显示出与TBR相似的趋势,并反映了尿NMN水平。SPECT/CT的半自动定量可能是评估疾病活动度的有用工具。